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Introduction 
This case involves  the  anesthetic 
management of a 15-year-old patient 
with thoracic aortic root dilatation 
presenting for multi-level spinal 
fusion for idiopathic scoliosis. The 
importance of perioperative 
hemodynamic monitoring and 
smooth arterial pressure 
management is emphasized in order 
to prevent aortic dissection. 
Case Description 
A patient with thoracic aortic root 
dilatation in Marfan Syndrome has 
an increased risk of perioperative 
aortic dissection, making strict 
control of blood pressure (BP) 
essential in the perioperative period. 
A 15-year-old, 92 kg male with 
Marfan Syndrome with thoracic 
aortic root dilatation presented for 
T3-L4 posterior spine 
instrumentation and fusion (PSIF). 
Preoperatively, he was started on 
losartan 50 mg, which was 
continued in the postoperative 
period. An arterial line was placed 
for close monitoring of BP in the 
intraoperative and postoperative 
period. We tightly controlled 
patient’s BP during induction, 
intubation, intraoperative period, 
extubation and postoperatively. 
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CONCLUSION  
 
In our case of multi-level posterior spinal fusion  
for idiopathic scoliosis, we continued losartan in 
the perioperative period and avoided swings in 





Cardiovascular manifestations of Marfan Syndrome1 
 
 Thoracic aortic root dilatation: Usually 
asymptomatic, frequency 60-80%, aortic dissection 
is the most common complication. Dissection is 
rare in children under the age of 10. 
 
 Pulmonary artery dilatation: Usually asymptomatic, 
frequency 75%, dissection is rare 
 
 Mitral valve prolapse, mitral regurgitation:  
Palpitations are usual symptoms, frequency 50-
70%, arrhythmias may be present 
 
 Descending aorta dilatation:  Usually 
asymptomatic, frequency 80-100%, increased risk 
of dissection in adults 
 
 Tricuspid valve prolapse: Patients most commonly 
asymptomatic, incidence is around 4% 
 
 Left ventricular dysfunction: Common presenting 
symptom is dyspnea.  Frequency is 100%, initially 
diastolic and may progress to systolic dysfunction. 
 
Medical therapy to prevent Progression of Aortic Root dilatation  
and Aortic Dissection1 
1. Beta blockers are the main mode of therapy2 
2.  Calcium channel blockers 
3. Angiotensin converting enzyme inhibitors 
4. Angiotensin receptor blockers 
Indication for Aortic Root Replacement Surgery in  
Thoracic Aortic Root Dilatation3 
1. Thoracic root diameter>5 cm 
2. Progressive dilatation>1 cm/year 
3.  Progressive aortic regurgitation 
Management Strategy for Patients with Marfan Syndrome with  
Thoracic Root Dilatation presenting for Major Surgery 
1. Close hemodynamic monitoring with invasive arterial line 
2. Avoid acute hemodynamic changes 
3. Continue the elective antihypertensive therapy in the perioperative period 
